Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fed Conditions

NCT03947528 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Sarpogrelate HCL 300mg

Sponsor

Daewoong Pharmaceutical Co. LTD.